TOP NEWS
NINTH CIRCUIT
POLICY & REGULATION
LITIGATION
PEOPLE
EXPERT ANALYSIS
Focusing On Fluoride: From FDA To Class Action
A class action filed two days after the U.S. Food and Drug Administration announced plans to remove ingestible fluoride prescription drug products for children from the market may be the tip of the iceberg in terms of the connection between government pronouncements on safety and their immediate use as evidence in lawsuits, says Rachel Turow at Skadden.
Complaint attached |
Read full article »
| Save to favorites »
LEGAL INDUSTRY
|